I got dangerously sick while waiting for double-lung and liver transplants. But then I got a second chance at life after starting Trikafta, even though I have two rare mutations.

Trikafta, made by Vertex Pharmaceuticals, is, as its name suggests, a combination of three drugs. It works for 90 percent of patients with cystic fibrosis, and will be priced at $311,000 per year.

Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and ...

There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their ...

It generates revenue through its cystic fibrosis drugs, Trikafta and Kalydeco, and is pioneering treatments for T1D, including VX-880, a stem cell-derived therapy aimed at restoring insulin ...

The patients of cystic fibrosis (CF), their families, and public health experts are pinning their hopes on the expected outcome from the Karnataka High Court regarding availability of affordable ...

My evolving relationship with cystic fibrosis brings feelings of guilt and jealousy but also a deep sense of gratitude and understanding.

A big part of why Prince-Saxon was even able to take on this feat is the drug Trikafta, which received public funding through Pharmac in April 2023 for people with CF aged six and over.

Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

About 75% of patients in these key geographies have started treatment with one of Vertex's most effective medicines, Trikafta. That number stands at 33% in other countries. Vertex recently earned ...